Representing ECPC as one of the members and promoting and working on good practices on EU and national level with collaboration with cancer patients advocates from all over Europe. Responsible for transparency and effective allocation of ECPC founding as well as supporting implementation of new projects and setting up partnerships.
Before retiring in 2005, Ken worked in management for 43 years: he has been part of the Committee of management of Benenden Healthcare Society Limited and of the Board of Governors of the Hospital, but he has also been Chairman of the Internal Audit Committee and Director of the Friends of Benenden.
Ken has served as Chairman of Europa Uomo. Currently, he is Chairman at couple of organisations such as Tackle Prostate Cancer UK and Association of prostate Cancer Patients in London and Essex. Ken is also involved in other organisations including EMA, EAU and ECCO.
Ken Mastris is a prostate cancer patient and patient advocate, committed to promote patients’ equality in cancer treatment and better quality of life for cancer patients, in all of Europe. He is dedicated to patient advocacy and he aims to ensure that cancer patients receive the right treatment at the right time, without suffering any additional stress during complex medical procedures. He strongly believes in treating each patient as an individual, whose point of view and voice shall be carefully listened to by health professionals. Ken is also involved in educating men to recognise symptoms and signals of prostate cancer, in order to maximise the chances of early diagnosis.
We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer.Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
legitimise our position of cancer patient representatives before decision-makers
build a reputation as a cancer patient expert within the scientific community
find partners sharing the same vision, values and goals to work together on projects
get the media’s attention in order to publish and disseminate our messages